Startups channel feed

DNA gi­ant Il­lu­mi­na spawned an ecosys­tem of com­peti­tors and cus­tomers

Yesterday
In Focus
Diagnostics

Ex­clu­sive: Move­ment dis­or­der biotech Vi­ma steps on­to scene with $60M

Yesterday
Financing

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

2 days ago
People
Health Tech

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

2 days ago
People

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

2 days ago
Financing

Bio­gen taps City Ther­a­peu­tics in RNAi deal worth up to $1B

3 days ago
Deals
Pharma

In­vestors pump $130M in­to pro­tein de­grad­er start­up Gly­co­Era

3 days ago
Financing

TCG's R&D ven­ture team makes a T cell en­gager deal with Shang­hai biotech

3 days ago
Deals
China

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

Last week
In Focus

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

Last week
Deals

Re­pro­duc­tive health biotech snags $65M to de­vel­op for­mer No­var­tis and Mer­ck KGaA drugs

Last week
Financing

UK biotech Ju­ve­nes­cence tar­gets $150M+ for 'healthy lifes­pan' drug can­di­dates

Last week
Financing

Ex­clu­sive: Weight loss start­up Cal­i­brate swaps CEOs in lat­est lead­er­ship shake­up

Last week
People
Health Tech

Retro Bio­sciences inks blood dis­or­der deal as Sam Alt­man-backed biotech seeks $1B in funds

Last week
Deals
Cell/Gene Tx

Ex­clu­sive: Cell­Cen­tric col­lects $120M to treat mul­ti­ple myelo­ma with a cap­sule

Last week
Financing

Ap­n­imed posts first set of Phase 3 sleep ap­nea re­sults, aims for ap­proval fil­ing in 2026

Last week
R&D

It's been three months with­out a biotech IPO

2 weeks ago
Financing

Eli Lil­ly turns to South Ko­re­an RNA edit­ing biotech for hear­ing loss in deal worth $1.3B

3 weeks ago
Deals
Cell/Gene Tx

Pathos AI col­lects $365M to fu­el 'bul­let­proof' on­col­o­gy tri­als and in-li­cense more can­cer drugs

3 weeks ago
Financing
AI

Ab­b­Vie dou­bles down on siR­NA with $335M up­front bet on ADARx

3 weeks ago
Deals
Pharma

Dutch biotech gets $146M for late-stage tri­als in three meta­bol­ic dis­or­ders

3 weeks ago
Financing

Ex­clu­sive: Patrick Hsu start­up launch­es, looks be­yond CRISPR for gene in­ser­tion tech­nol­o­gy

3 weeks ago
Cell/Gene Tx

Chron­ic care start­up Oma­da Health files to go pub­lic

3 weeks ago
Financing
Health Tech

AI biotech In­sil­i­co Med­i­cine goes for third at­tempt at Hong Kong IPO

3 weeks ago
Financing
AI
1234 Next page Last page
A service from the Financial Times